Compare AdaptHealth Corp (AHCO) vs Ulta Beauty Inc (ULTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AdaptHealth Corp vs Ulta Beauty Inc — how do they compare? AdaptHealth Corp trades at $5.81 (market cap $753.09M), while Ulta Beauty Inc trades at $533.72 (market cap $23.27B). The key difference: Ulta Beauty Inc is far larger — about 30.9× AdaptHealth Corp's market cap, and Ulta Beauty Inc is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | ULTA | |
|---|---|---|
Market Cap | $753.09M | $23.27B |
Sector | Health | Consumer Cyclical |
52-Week High | $13.38 | $706.82 |
52-Week Low | $5.22 | $450.75 |
Enterprise Value | $2.77B | $25.35B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth Corp. (AHCO) trades at $5.74, up 9.96% in the last session, yet remains under pressure with a bearish technical signal and recent earnings misses. The company reported a Q2 2026 net loss of $228 million with a -6.82% margin, while selling its diabetes unit to focus on sleep and respiratory care. Valuation ratios show a low P/S of 0.23 and P/B of 0.55, but negative profitability metrics highlight operational challenges.
The outlook is mixed: analyst consensus is bullish with a $11 price target, but risks include ongoing losses, fraud investigations, and cost overruns in fixed-price contracts. Upside depends on successful business restructuring and margin improvement, while downside risks from legal and execution issues persist.
Ulta Beauty (ULTA) trades at $537.69, down 2.0% today, with a bullish technical outlook from moving averages and a consensus analyst price target of $618.29. Recent earnings show mixed quarterly beats, with Q1 2026 EPS of $7.74 exceeding expectations, while revenue growth remains steady at $11.3B for 2025. The company maintains strong profitability with a net margin of 9.36% and ROE of 47.45%, supported by an omnichannel strategy highlighted in recent news.
The stock presents a buy opportunity with Wall Street optimism (56.53% buy ratings) and solid fundamentals, but risks include margin compression from rising costs and competitive pressures. Near-term catalysts include the Q2 2026 earnings report, with expected EPS of $6.17, and the transition from the Target partnership, viewed as a growth opportunity by analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Ulta Beauty Inc
With more than 1,300 stores and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the U.S. The firm offers makeup (43% of 2021 sales), fragrances, skin care, and hair care products (20% of 2021 sales), and bath and body items. Ulta offers private-label products and merchandise from more than 500 vendors. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
Read more on ULTA →
